India to resume export of surplus COVID-19 vaccines from next month

India will resume export of vaccines against COVID-19 in October 2021 under the ‘Vaccine Maitri’ programme, the health ministry announcement on Monday.

India will resume export of vaccines against COVID-19 under the ‘Vaccine Maitri’ programme and to meet its commitment to the COVAX, but vaccinating its own citizens remains the topmost priority of the government,” Union health minister Mansukh Mandaviya said.

Centre will receive more than 30 crore doses of COVID-19 vaccines in October and more than 100 crore doses in the next three months, the union minister said.

He further stated that aggregate doses administered till now across India have crossed the mark of 81 crore and the in last 11 days 10 crore doses were administered.

The surplus supply of Covid-19 vaccines will be used to fulfil India’s commitment towards the world for the collective fight against pandemic.

COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO.

Speaking about the expected production in the coming months, he said that over 30 crore doses will be produced in October and more than 100 crores in the coming quarter.

Therefore he said, India’s vaccination drive has been a role model for the world and it is marching ahead with great speed.

(Inputs from PTI)


Latest Indian news

Popular Stories

Latest Video

error: Content is protected !!